Delivery Order SPE2DB22D2211-SPE2DB25FRKVM

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of TWINRIX VACCINE SYRINGEML. The $5,174.14 firm-fixed price delivery order, which has an ultimate completion date of February 13, 2025, does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. The $14,276.80 fixed-price delivery order is for the TWINRIX VACCINE SYRINGE, a vaccine product. This award has no set-aside designation, indicating open competition. Amerisourcebergen has a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $6,403.66 firm fixed-price delivery order contract for TWINRIX VACCINE SYRINGEML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceutical products, to support military treatment programs and facilities...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of TWINRIX VACCINE SYRINGEML. The $2,156.48 firm fixed-price delivery order has an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order with a ceiling value of $31,410.80, issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of TWINRIX vaccine syringes and has a completion date of July 23, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TWINRIX vaccine syringes, at a firm fixed price of $1,389.26, with a completion date of May 3, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,747.52 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, with a period of performance through May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,802.40 firm fixed-price delivery order is for the supply of the TWINRIX vaccine in syringes. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,773.90 Firm Fixed Price delivery order contract is for the supply of the TWINRIX VACCINE SYRINGE ML product. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,379.16 Firm Fixed Price delivery order is for the supply of Twinrix vaccine syringes. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRKVM
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,777.16 for the supply of the TWINRIX VACCINE SYRINGE. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of November 27, 2024. The contract is a firm fixed-price agreement and is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/25/25, 9:49 AM